AbbVie sues US health agency over Botox price controls

Core Viewpoint - AbbVie has filed a lawsuit against the U.S. Department of Health and Human Services, contesting the decision made by the Centers for Medicare & Medicaid Services to implement price controls on Botox [1] Company Summary - AbbVie is challenging the price control measures imposed on Botox, which could impact its revenue from this product [1]